Statera Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cash & Equivalents	1.84	0.59	0	0.01
Short-Term Investments	0.13	-	-	-
Cash & Short-Term Investments	1.98	0.59	0	0.01
Cash Growth	233.29%	35892.06%	-85.03%	-
Accounts Receivable	0.35	-	-	-
Other Receivables	-	0.33	-	-
Receivables	0.35	0.33	-	-
Prepaid Expenses	0.98	-	-	-
Other Current Assets	0.85	0	-	0.42
Total Current Assets	4.16	0.93	0	0.43
Property, Plant & Equipment	1.17	0.11	-	-
Goodwill	9.27	-	-	-
Other Intangible Assets	1.58	-	-	-
Other Long-Term Assets	5	-	-	-
Total Assets	21.17	1.04	0	0.43
Accounts Payable	3.96	1.13	2.41	1.71
Accrued Expenses	1.75	1.55	-	-
Short-Term Debt	4.58	1.9	1.8	1.57
Current Portion of Leases	0.25	0.03	-	-
Current Unearned Revenue	0.37	-	-	-
Other Current Liabilities	0.33	-	-	-
Total Current Liabilities	11.25	4.62	4.21	3.29
Long-Term Debt	10.63	-	-	-
Long-Term Leases	0.81	0.07	-	-
Total Liabilities	22.68	4.69	4.21	3.29
Common Stock	0.18	0.16	0.02	0.02
Additional Paid-In Capital	127.74	23.95	11.31	9.43
Retained Earnings	-129.48	-27.76	-15.54	-12.31
Comprehensive Income & Other	-0.01	-	-	-
Total Common Equity	-1.57	-3.66	-4.21	-2.86
Minority Interest	0.06	-	-	-
Shareholders' Equity	-1.51	-3.66	-4.21	-2.86
Total Liabilities & Equity	21.17	1.04	0	0.43
Total Debt	16.26	2	1.8	1.57
Net Cash (Debt)	-14.28	-1.41	-1.8	-1.56
Net Cash Per Share	-0.41	-0.19	-0.09	-0.09
Filing Date Shares Outstanding	51.14	24.34	20.35	17.1
Total Common Shares Outstanding	35.48	24.34	20.35	17.1
Working Capital	-7.09	-3.7	-4.21	-2.86
Book Value Per Share	-0.04	-0.15	-0.21	-0.17
Tangible Book Value	-12.42	-3.66	-4.21	-2.86
Tangible Book Value Per Share	-0.35	-0.15	-0.21	-0.17
Machinery	0.23	0.01	-	-

Updated Nov 14, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.